(Nonalcoholic fatty liver disease (NAFLD. (Nonalcoholic fatty liver disease (NAFLD
Conditions
Interventions
Intervention 1: intervention group: Omega-3 supplement with effective dosage of 900 mg/day, 3*300 mg capsules per day for 2 month. Intervention 2: control group: 3 capsules of placebo per day for 2 mo
Treatment - Drugs
Placebo
intervention group: Omega-3 supplement with effective dosage of 900 mg/day, 3*300 mg capsules per day for 2 month
control group: 3 capsules of placebo per day for 2 month
Sponsors
Ahvaz Jundishapur University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Inclusion criteria:patient>18 year; elevated Alanine aminotransfrase for up to 6 month before beginning of the study; lack of excessive alcohol ingestion; ultrasound examination; negative diagnostic tests for viral hepatitis; absence of other causes of liver disease. Exclusion criteria: a history of alcohol intake; the use of drugs known to be associated with liver steatosis; undernutrition; pregnantand breastfeeding women.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipid profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Inflammatory markers. Timepoint: before intervention and 2 months after intervention. Method of measurement: ELISA.;Sugar profile. Timepoint: before intervention and 2 months after intervention. Method of measurement: mg/dl with autoanalyzer.;Insulin Resistance. Timepoint: before intervention and 2 months after intervention. Method of measurement: HOMA-IR. | — |
Secondary
| Measure | Time frame |
|---|---|
| Liver enzymes. Timepoint: before intervention and 2 months after intervention. Method of measurement: Autoanalyzer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Saeed Shirali
Ahvaz Jundishapur University of Medical Sciences
Outcome results
None listed